Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Front Immunol
Prif Awduron: Mohr, Raphael, Jost-Brinkmann, Fabian, Özdirik, Burcin, Lambrecht, Joeri, Hammerich, Linda, Loosen, Sven H., Luedde, Tom, Demir, Münevver, Tacke, Frank, Roderburg, Christoph
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2021
Pynciau:
Immunology
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://ncbi.nlm.nih.gov/pubmed/33859646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652172
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg